BridgeMD
New treatment option for Atrial Fibrillation
Official title Optimizing Quality of Life by Improved Patient Expectation Following Atrial Fibrillation Catheter Ablation
ClinicalTrials.gov ID: NCT05557526
What this study is testing
- What it's testing
- The aim is to investigate whether optimizing patients' expectations towards the interventional treatment of atrial fibrillation (catheter ablation) leads to a lower disease-related impairment of the patients compared to the control group in the first three months after ablation (the so-called blanking period).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- symptomatic atrial fibrillation
- indication for pulmonary vein isolation
- sufficient command of the German language
You likely can't join if
- age \<18 years
- permanent atrial fibrillation
- presence of psychiatric disorders which impair the study participitatin
- presence of another medical condiction which influences quality of life stronger than the cardiac condition
- atrial fibrillation induced by intoxication, medicamentation or infection
- inability to grap the course of the study
The study team makes the final eligibility decision.
Where it's taking place
- Düsseldorf, North Rhine-Westfalia, Germany
- Essen, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Düsseldorf, North Rhine-Westfalia, Germany; Essen, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.